News

Take our short, two-question survey to help us ensure you have the answers you need.

CPhA is surveying pharmacists across Canada about the impacts of drug shortages and recalls on their practice and their patients.

CPhA has developed a tool to help patients and health-care providers select an alternative agent to bupropion.

CPhA calls on the federal government to convene a national meeting of key stakeholders with the goal of developing clear and actionable solutions to help resolve the problem of manufacturing and supply chain disruptions that lead to drug shortages.

CPhA announces new practice tool to help pharmacists talk to their patients about cannabis for medical purposes.

Patient-centred collaborative discussion paper aims to inform pharmacare discussion.

Several drugs containing valsartan being recalled due to contamination with a potential carcinogen.

CPhA welcomes the creation of the Advisory Council on the Implementation of National Pharmacare and we look forward to engaging with the Council as they develop their recommendations.